Please login to the form below
asthma
This page shows the latest asthma news and features for those working in and with pharma, biotech and healthcare.
AZ, Amgen file first-in-class asthma drug with the FDA
AstraZeneca (AZ) and Amgen have submitted a biologic license application (BLA) for their first-in-class asthma drug tezepelumab to the US Food and Drug Administration (FDA). ... AZ and Amgen are seeking approval for tezepelumab for the treatment of
Latest news
-
GSK’s revenue drops by 18% in Q1 as performance pressures mount
acting severe asthma treatment.
-
FDA approves new self-injection administration for Xolair
Drug is approved for asthma and other allergic and inflammatory conditions. ... This includes a number of allergic and inflammatory conditions, including moderate-to-severe persistent allergic asthma, chronic idiopathic urticaria (CIU) and nasal polyps.
-
Oxford study finds standard asthma medication improves recovery time in COVID-19 patients
Inhaled budesonide – a type of corticosteroid medication – is commonly used to treat asthma and chronic obstructive pulmonary disease. ... The inhaled asthma drug was given to 751 people within the first two weeks of symptom onset, while 1, 028 were
-
AZ, Amgen’s tezepelumab reduces asthma exacerbations in broad patient population
options. For every key secondary endpoint, tezepelumab also demonstrated statistically significant improvements on each count, including lung function measurements, asthma control and health-related quality of life. ... class medicine to a broad
-
AZ forecasts growth in 2021 after revenues surge in Q4
However, AZ did report that the pandemic had a significant impact on certain medicines, including sales of asthma/COPD treatment Pulmicort (budesonide) in China and some decreased use of infused/injectable
More from news
Approximately 66 fully matching, plus 493 partially matching documents found.
Latest Intelligence
-
Mapping at launch: it’s time to update the satnav
COPD. It has recently been approved by the FDA for asthma too, but our analysis focuses on UK performance.
-
On our best behaviour
Historically, asthma patients were responsible for recording their own symptoms and exacerbations, which can be difficult to remember over long periods. ... The Propeller platform has been shown to increase medication adherence by up to 58%, increase
-
Exploring the potential of eosinophils
Working as a clinician at this time meant he was caring for patients with allergies and asthma, in particular severe asthma. ... Sputum provides a sample of the central airways which only makes up 10% of the airways, but asthma affects the whole of the
-
Could formulary intelligence be your brand differentiator?
Sirdupla – a branded generic to Seretide (asthma), offering good cost savings for medicines management.
-
AI: the smart money is on the smart thinking
The software helps differentiate patients from those suffering with similar symptoms that are actually a result of asthma and chronic obstructive pulmonary disease (COPD), and therefore diagnose CTEPH more reliably and
More from intelligence
Approximately 3 fully matching, plus 48 partially matching documents found.
Latest appointments
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
inflammation test for managing asthma, across key markets such as the United States, China, and Japan, as well as the rest of the world.
-
Takeda UK & Ireland appoints market access director
company's first respiratory biologic for severe asthma.
-
Enterprise Therapeutics appoints CEO
In his new role, Dr Ford will oversee the development of the company's novel muco-regulatory therapies for patients suffering with chronic obstructive pulmonary disease, cystic fibrosis and severe asthma.
-
Former RBS head takes the reins as GSK chair
the past year, and to develop new products in order to offset the decline of its best-selling asthma drug, Advair, as part of his new remit.
-
GSK's Dr Brett Haumann takes up chief medical officer role at Circassia
Most recently these saw him serve as VP and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD).
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Latest from PMHub
-
Article
Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma. ... Head of “Living With”, Mariel Metcalfe, discusses the nature of severe asthma and severe eosinophilic asthma, and some key findings from recent studies
-
Addressing Climate Impact: The Healthcare Paradox
Boehringer Ingelheim recently introduced the first reusable, propellant-free inhaler for patients with asthma and COPD, supporting objectives of carbon and plastic waste reduction.
-
How will the Tories’ historic win shape the NHS?
conditions remotely, has huge potential for the NHS. For example, with long term conditions such as asthma and diabetes, remote monitoring enables better self-management, which in turn, should lead to
-
Digital therapeutics and their impact on society
This is in part due to the explosive, bordering on unmanageable, increase in chronic diseases, such as cardiovascular disease, diabetes, Alzheimer’s disease, obesity and asthma.
-
RWE Blog 1: Real-world challenges and real-world data
In a review of 870 out-patients with asthma and/or Chronic Obstructive Pulmonary Disease (COPD), only one in 20 asthma patients and one in six COPD patients met the typical
More from PMHub
Approximately 3 fully matching, plus 21 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
-
Associate Account Director
-
Competitive Salary
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
- Senior & Principal Medical Writer
-
Competitive Salary Offered
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
-
Publications Director
-
Competitive Salary
-
Account Management
-
Competitive Salary Offered
-
Medical Editor
-
Competitive Salary
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
-
Senior Account Executive
-
Competitive Salary
-
Account Manager
-
Competitive Salary
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
-
Senior Medical Writer
-
Competitive Salary
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- Merck & Co reveals plans for women’s health spinoff Organon
- bluebird bio aiming to separate business units by year-end
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- Lilly signs $1.25bn collaboration deal with MiNA Therapeutics
- Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021
- Emergency authorisation for Pfizer/BioNTech vaccine expanded in the US
- Biogen and Capsigen to collaborate on gene therapies
- AZ, Amgen file first-in-class asthma drug with the FDA
- Sharing patient stories for World Pulmonary Hypertension Day
- Single dose of COVID-19 vaccines ‘significantly’ reduces infections
- AZ, Amgen file first-in-class asthma drug with the FDA
- US states claim Purdue Pharma owes $2.2 trillion over opioid crisis
- The new reality of building a corporate brand in pharma
- FDA approves expanded use for Chiesi’s sickle cell drug Ferriprox
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Sharing patient stories for World Pulmonary Hypertension Day
- For World Pulmonary Hypertension Day and we’re here to help raise awareness of pulmonary hypertension (PH) - a frequently under and misdiagnosed condition. Created in collaboration with the PH patient...
- How nature can help you manage the pressures of agency life
- Paul Hutchings, founder of fox&cat, outlines how nature can help you can boost staff wellbeing in your agency this Mental Health Awareness Week...
- How can we strike the right balance between familiarity and innovation when it comes to data presentation?
- Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
